SCHEMBL26303

SCHEMBL26303

CCCC[C](C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27735838 0.96
SCHEMBL43240 0.89
SCHEMBL283568 0.86 CES2 (0.55)
SCHEMBL1264129 0.86 CES2 (0.55)
SCHEMBL1507486 0.86 CES2 (0.55)
SCHEMBL987400 0.86 CES2 (0.55)
SCHEMBL1507451 0.86 CES2 (0.55)
SCHEMBL782200 0.86 CES2 (0.55)
SCHEMBL330254 0.86 CES2 (0.50)
SCHEMBL21810686 0.86 CES2 (0.55)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6790 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024125775-A1 IMPROVED PROCESS FOR THE PREPARATION OF METAL ALCOHOLATE COMPOUNDS EVONIK OPERATIONS GMBH (DE) 2024-06-20 WO claimed
WO-2024126086-A1 IMPROVED PROCESS FOR PREPARING METAL ALKOXIDE COMPOUNDS EVONIK OPERATIONS GMBH (DE) 2024-06-20 WO claimed
WO-2024120883-A1 IMPROVED PROCESS FOR PREPARING METAL ALKOXIDE COMPOUNDS EVONIK OPERATIONS GMBH (DE) 2024-06-13 WO claimed
WO-2024091258-A1 ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS- COV-2 VACCINES COMPOSITION AND METHODS D4 LABS, LLC (US) 2024-05-02 WO claimed
CN-117940157-A Adjuvant-containing vaccine compositions and methods D4实验室有限责任公司 2024-04-26 CN claimed
WO-2024083322-A1 IMPROVED METHOD FOR THE DEPOLYMERISATION OF POLYETHYLENE TEREPHTHALATE EVONIK OPERATIONS GMBH (DE) 2024-04-25 WO claimed
WO-2024083336-A1 IMPROVED PROCESS FOR PRODUCTION OF ALKALI METAL METHOXIDES EVONIK OPERATIONS GMBH (DE) 2024-04-25 WO claimed
US-20240131139-A1 ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS-COV-2 VACCINES COMPOSITION AND METHODS D4 LABS, LLC 2024-04-25 US claimed
US-20240131040-A1 COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS Natural Extraction Systems, LLC (US) 2024-04-25 US claimed
EP-4326320-A1 ADJUVANTED VACCINE COMPOSITION AND METHODS D4 LABS, LLC (US) 2024-02-28 EP claimed
US-4123441-A Enlarged-hetero-ring prostacyclin analogs THE UPJOHN COMPANY (US) 1978-10-31 US claimed
US-4113863-A PROSTENOIC ACID DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1978-09-12 US claimed
US-4110368-A PROSTAGLANDINS, BRONCHODILATOR, ANTIULCER AMERICAN CYANAMID COMPANY (US) 1978-08-29 US claimed
US-4086362-A Prostenoic acid derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1978-04-25 US claimed
US-4080458-A HYPOTENSIVE AGENTS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) 1978-03-21 US claimed
US-4055597-A RENAL VASODILATORS MERCK & CO., INC. (US) 1977-10-25 US claimed
US-4012429-A OXYTOCICS, ANTISECRETORY AGENTS SANKYO COMPANY LIMITED (JA) 1977-03-15 US claimed
US-4007210-A PROSTANOIC ACID DERIVATIVES AMERICAN CYANAMID COMPANY (US) 1977-02-08 US claimed
US-4004927-A Photographic light-sensitive material containing liquid organopolysiloxane FUJI PHOTO FILM CO., LTD. (JA) 1977-01-25 US claimed
US-3970692-A Process for the preparation of prostaglandin F2.sub.α and the analogs thereof SCHERING AKTIENGESELLSCHAFT (DT) 1976-07-20 US claimed